| Line Item | 2024-01-01 | Y/Y |
|---|---|---|
| Revenue | $2.23B | -10.5% |
| Cost of Revenue | $1.82B | -10.7% |
| Gross Profit | $413.3M | -9.8% |
| R&D Expense | $27.3M | +9.9% |
| SG&A Expense | $149.6M | -5.4% |
| Operating Income | $42.3M | -79.9% |
| Interest Expense | $48.1M | +5.7% |
| Pre-tax Income | $297K | -99.8% |
| Income Tax | $19.0M |
| Line Item | 2024-01-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $450.2M | +11.8% |
| Accounts Receivable | $413.6M | -12.6% |
| Inventory | $213.1M | +24.9% |
| Current Assets | $1.43B | -4.2% |
| Total Assets | $3.32B | +0.0% |
| Current Liabilities | $704.0M | -7.5% |
| Long-term Debt | $914.3M | +4.0% |
| Line Item | 2024-01-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $187.3M | -31.4% |
| Capital Expenditures | $160.2M | +55.8% |
| Investing Cash Flow | -$92.0M | +76.7% |
| Financing Cash Flow | -$47.7M | -321.5% |
| Free Cash Flow | $27.0M | -84.1% |
| -78.5% |
| Net Income | -$18.7M | -119.8% |
| EPS (Basic) | -$0.18 | -119.4% |
| EPS (Diluted) | -$0.18 | -119.8% |
| Stockholders' Equity |
| $1.51B |
| -1.6% |